BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11207222)

  • 1. Brain specific proteins in posthaemorrhagic ventricular dilatation.
    Whitelaw A; Rosengren L; Blennow M
    Arch Dis Child Fetal Neonatal Ed; 2001 Mar; 84(2):F90-1. PubMed ID: 11207222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants.
    Blennow M; Sävman K; Ilves P; Thoresen M; Rosengren L
    Acta Paediatr; 2001 Oct; 90(10):1171-5. PubMed ID: 11697430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of nerve tissue injury in the cerebrospinal fluid in patients with lumbar disc herniation and sciatica.
    Brisby H; Olmarker K; Rosengren L; Cederlund CG; Rydevik B
    Spine (Phila Pa 1976); 1999 Apr; 24(8):742-6. PubMed ID: 10222523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory brain stem responses in infants with posthaemorrhagic ventricular dilatation.
    Lary S; De Vries LS; Kaiser A; Dubowitz LM; Dubowitz V
    Arch Dis Child; 1989 Jan; 64(1 Spec No):17-23. PubMed ID: 2647041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolysis in cerebrospinal fluid after intraventricular haemorrhage.
    Whitelaw A; Creighton L; Gaffney P
    Arch Dis Child; 1991 Jul; 66(7 Spec No):808-9. PubMed ID: 1863129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative cranial ultrasound prediction of severity of disability in premature infants with post-haemorrhagic ventricular dilatation.
    Jary S; Kmita G; Wroblewska J; Whitelaw A
    Arch Dis Child; 2012 Nov; 97(11):955-9. PubMed ID: 22941857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of posthaemorrhagic ventricular dilatation.
    Whitelaw A; Aquilina K
    Arch Dis Child Fetal Neonatal Ed; 2012 May; 97(3):F229-3. PubMed ID: 21289015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine response in cerebrospinal fluid from preterm infants with posthaemorrhagic ventricular dilatation.
    Sävman K; Blennow M; Hagberg H; Tarkowski E; Thoresen M; Whitelaw A
    Acta Paediatr; 2002; 91(12):1357-63. PubMed ID: 12578295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posthaemorrhagic ventricular dilatation.
    Whitelaw A; Thoresen M; Pople I
    Arch Dis Child Fetal Neonatal Ed; 2002 Mar; 86(2):F72-4. PubMed ID: 11882544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired brain growth and neurodevelopment in preterm infants with posthaemorrhagic ventricular dilatation.
    Jary S; De Carli A; Ramenghi LA; Whitelaw A
    Acta Paediatr; 2012 Jul; 101(7):743-8. PubMed ID: 22452585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS.
    Avasarala JR
    Neurology; 2004 Aug; 63(3):599; author reply 599. PubMed ID: 15304618
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment thresholds for intervention in posthaemorrhagic ventricular dilation: a randomised controlled trial.
    de Vries LS; Groenendaal F; Liem KD; Heep A; Brouwer AJ; van 't Verlaat E; Benavente-Fernández I; van Straaten HL; van Wezel-Meijler G; Smit BJ; Govaert P; Woerdeman PA; Whitelaw A;
    Arch Dis Child Fetal Neonatal Ed; 2019 Jan; 104(1):F70-F75. PubMed ID: 29440132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS.
    Malmeström C; Haghighi S; Rosengren L; Andersen O; Lycke J
    Neurology; 2003 Dec; 61(12):1720-5. PubMed ID: 14694036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posthemorrhagic ventricular dilatation-impact on early neurodevelopmental outcome.
    Srinivasakumar P; Limbrick D; Munro R; Mercer D; Rao R; Inder T; Mathur A
    Am J Perinatol; 2013 Mar; 30(3):207-14. PubMed ID: 22898993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International randomised controlled trial of acetazolamide and furosemide in posthaemorrhagic ventricular dilatation in infancy. International PHVD Drug Trial Group.
    Lancet; 1998 Aug; 352(9126):433-40. PubMed ID: 9708751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial lumbar tapping to prevent posthaemorrhagic hydrocephalus after intracranial haemorrhage in preterm infants.
    Müller W; Urlesberger B; Maurer U; Kuttnig-Haim M; Reiterer F; Moradi G; Pichler G
    Wien Klin Wochenschr; 1998 Oct; 110(18):631-4. PubMed ID: 9816635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose intraventricular fibrinolytic treatment to prevent posthaemorrhagic hydrocephalus.
    Whitelaw A; Rivers RP; Creighton L; Gaffney P
    Arch Dis Child; 1992 Jan; 67(1 Spec No):12-4. PubMed ID: 1536579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posthaemorrhagic ventricular dilatation: new mechanisms and new treatment.
    Whitelaw A; Cherian S; Thoresen M; Pople I
    Acta Paediatr Suppl; 2004 Feb; 93(444):11-4. PubMed ID: 15035455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter to the Editor. Management of preterm infants with posthemorrhagic ventricular dilatation.
    Riazi A; Salehpour F; Mirzaei F; Mahdkhah A
    J Neurosurg Pediatr; 2022 Feb; 29(5):597-598. PubMed ID: 35120319
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrospinal fluid plasminogen activator inhibitor-1: a prognostic factor in posthaemorrhagic hydrocephalus.
    Hansen A; Whitelaw A; Lapp C; Brugnara C
    Acta Paediatr; 1997 Sep; 86(9):995-8. PubMed ID: 9343282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.